Veracyte (NASDAQ:VCYT – Get Free Report) issued its quarterly earnings results on Tuesday. The biotechnology company reported ($0.12) earnings per share for the quarter, beating the consensus estimate of ($0.16) by $0.04, Briefing.com reports. The business had revenue of $90.32 million for the quarter, compared to the consensus estimate of $83.05 million. Veracyte had a […]
Veracyte (NASDAQ:VCYT – Get Free Report) is scheduled to be issuing its quarterly earnings data after the market closes on Tuesday, August 8th. Analysts expect the company to announce earnings of ($0.16) per share for the quarter. Parties interested in listening to the company’s conference call can do so using this link. Veracyte (NASDAQ:VCYT – […]
Veracyte (NASDAQ:VCYT – Get Free Report) is scheduled to announce its earnings results after the market closes on Tuesday, August 8th. Analysts expect the company to announce earnings of ($0.16) per share for the quarter. Veracyte has set its FY 2023 guidance at EPS.Investors that wish to listen to the company’s conference call can do […]
Shares of Veracyte, Inc. (NASDAQ:VCYT – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the six analysts that are currently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, one has issued a hold rating and four have given a buy rating to […]
Nikko Asset Management Americas Inc. increased its position in Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 7.5% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,293,645 shares of the biotechnology company’s stock after purchasing an additional 229,200 shares during […]